Amedeo Smart

Free Medical Literature Service

 

Amedeo

Irritable Bowel Syndrome
  Free Subscription

Articles published in
Am J Gastroenterol
    April 2024
  1. HANNA-JAIRALA I, Drossman DA
    CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN.
    Am J Gastroenterol. 2024 Apr 9. doi: 10.14309/ajg.0000000000002800.
    >> Share

    March 2024
  2. CASH BD
    Congratulations. You Have Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002734.
    >> Share

  3. SHIN A, Xu H
    Healthcare Costs of Irritable Bowel Syndrome (IBS) and IBS Subtypes in the United States.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002753.
    >> Share

    January 2024
  4. LEMBO AJ, Chey WD, Harris LA, Frazier R, et al
    Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002685.
    >> Share

  5. LI F, Yano Y, Etievant L, Daniel CR, et al
    The Time-Dependent Association between Irritable Bowel Syndrome and All-cause and Cause-specific Mortality: A Prospective Cohort Study within the UK Biobank.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002675.
    >> Share

  6. VAN TILBURG MAL, Rana H
    Well-Being of Patients With Irritable Bowel Syndrome: A Shift From Measuring Deficits to Strengths?
    Am J Gastroenterol. 2024 Jan 2. doi: 10.14309/ajg.0000000000002601.
    >> Share


  7. American College of Gastroenterology Monograph on Microbiome Therapeutics.
    Am J Gastroenterol. 2024;119.
    >> Share

    October 2023
  8. SNIJKERS JTW, Winkens B, Weerts ZZRM, Vork L, et al
    Satisfaction with life in IBS is associated with psychological burden rather than gastrointestinal symptom severity.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002547.
    >> Share

    September 2023
  9. TOPAN R, Vork L, Fitzke BSocSci H, Pandya S, et al
    Poor subjective sleep quality predicts symptoms in Irritable Bowel Syndrome using the Experience Sampling Method.
    Am J Gastroenterol. 2023 Sep 22. doi: 10.14309/ajg.0000000000002510.
    >> Share

    May 2023
  10. KHAN Z
    Continuing Medical Education Questions: May 2023.
    Am J Gastroenterol. 2023;118:779.
    >> Share

    April 2023
  11. BALLOU S, Rangan V, Eidelberg A, Proctor S, et al
    What is unspecified functional bowel disorder? A commonly seen, rarely recognized, and poorly understood diagnosis.
    Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002281.
    >> Share

  12. YANG PL, Kamp KJ, Burr RL, Tang HJ, et al
    Age Differences in Core Symptoms and Symptom Relationships in Patients with Irritable Bowel Syndrome: A Network Analysis.
    Am J Gastroenterol. 2023 Apr 11. doi: 10.14309/ajg.0000000000002280.
    >> Share

    February 2023
  13. SALEH ZM, Chey WD, Berry S
    Behavioral Health Digital Therapeutics for Patients with Irritable Bowel Syndrome: A Primer for Gastroenterologists.
    Am J Gastroenterol. 2023 Feb 16. doi: 10.14309/ajg.0000000000002220.
    >> Share

    January 2023
  14. DAMIANOS JA, Tomar SK, Azpiroz F, Barba E, et al
    Abdominophrenic Dyssynergia: A Narrative Review.
    Am J Gastroenterol. 2023;118:41-45.
    >> Share

    December 2022
  15. BAI T, Xu Z, Xia P, Feng Y, et al
    The Short-term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism rather than Diversity Regulation.
    Am J Gastroenterol. 2022 Dec 23. doi: 10.14309/ajg.0000000000002147.
    >> Share

  16. GEARRY R, Fukudo S, Barbara G, Kuhn-Sherlock B, et al
    Consumption of two green kiwifruit daily improves constipation and abdominal comfort - results of an international multicentre randomised controlled trial.
    Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002124.
    >> Share

  17. JONES MP, Guthrie-Lyons L, Sato YA, Talley NJ, et al
    Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials.
    Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002097.
    >> Share

  18. SPIEGEL B
    Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2022;117:1933-1947.
    >> Share

    November 2022
  19. D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
    Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
    Am J Gastroenterol. 2022 Nov 25. doi: 10.14309/ajg.0000000000002052.
    >> Share

    October 2022
  20. BRENNER DM, Lacy BE, Ford AC, Bartolini W, et al
    Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials.
    Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00551.
    >> Share

    September 2022
  21. VILLANUEVA-MILLAN MJ, Leite G, Wang J, Morales W, et al
    Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00500.
    >> Share

    August 2022
  22. NORDIN E, Hellstrom PM, Brunius C, Landberg R, et al
    Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome, a FODMAP and gluten trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00449.
    >> Share

    July 2022
  23. VOLLEBREGT PF, Wiklendt L, Burgell RE, Chaichanavichkij P, et al
    Abnormal Perception of Urge to Defecate: An Important Pathophysiological Mechanism in Women With Chronic Constipation.
    Am J Gastroenterol. 2022;117:1125-1136.
    >> Share

    June 2022
  24. HUANG Z, Lin Z, Lin C, Chu H, et al
    Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
    >> Share

  25. TACK J, Tornblom H, Tan V, Carbone F, et al
    Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
    Am J Gastroenterol. 2022;117:965-972.
    >> Share

    May 2022
  26. VAN DEN HOUTE K, Bercik P, Simren M, Tack J, et al
    Mechanisms underlying food-triggered symptoms in disorders of gut-brain interactions.
    Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00357.
    >> Share

  27. DULANEY DT
    Continuing Medical Education Questions: May 2022.
    Am J Gastroenterol. 2022;117:720.
    >> Share

  28. LACY BE, Cangemi DJ
    A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.
    Am J Gastroenterol. 2022;117:701-705.
    >> Share

    April 2022
  29. ZHANG X, Xiao X, Yang JL
    Shall we reduce endoscopy in patients with irritable bowel syndrome?
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00342.
    >> Share

  30. SINGH P, Tuck C, Gibson PR, Chey WD, et al
    The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
    Am J Gastroenterol. 2022 Apr 8. pii: 00000434-990000000-00347.
    >> Share

  31. BRENNER DM, Harris LA, Chang CH, Waldman SA, et al
    Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    >> Share

  32. KASSEBAUM-LADEWSKI A, Poppers DM, Brenner DM
    Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    >> Share

  33. SAYUK GS, Waldman SA, Brenner DM
    Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    >> Share

  34. HARRIS LA, Chang CH
    Burden of Constipation: Looking Beyond Bowel Movements.
    Am J Gastroenterol. 2022;117.
    >> Share

  35. BRENNER DM
    Best Practices for the Management of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation: A Roundtable Discussion and Review.
    Am J Gastroenterol. 2022;117.
    >> Share

    March 2022
  36. PIMENTEL M, Mathur R, Wang J, Chang C, et al
    A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00275.
    >> Share

  37. TAKAKURA W, Pimentel M, Rao S, Villanueva-Millan MJ, et al
    A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth.
    Am J Gastroenterol. 2022;117:470-477.
    >> Share

    February 2022
  38. WU S, Yuan C, Liu S, Zhang Q, et al
    Irritable bowel syndrome and long-term risk of cancer: a prospective cohort study among 0.5 million adults in UK Biobank.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00239.
    >> Share

    January 2022
  39. KIKUCHI S, Oe Y, Ito Y, Sozu T, et al
    Group cognitive behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00236.
    >> Share

  40. SCARLATA K, Eswaran S, Baker JR, Chey WD, et al
    Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology.
    Am J Gastroenterol. 2022 Jan 11. pii: 00000434-990000000-00184.
    >> Share

  41. SPIEGEL BMR, Liran O, Gale R, Khalil C, et al
    QUALITATIVE VALIDATION OF A NOVEL VIRTUAL REALITY (VR) PROGRAM FOR IRRITABLE BOWEL SYNDROME: A VR1 STUDY.
    Am J Gastroenterol. 2022 Jan 7. pii: 00000434-990000000-00189.
    >> Share

    December 2021
  42. GUZMAN-CARCAMO A, Navarro Gerrard C, Severino Ferreras I, Lopez Gomez J, et al
    P073 Diagnostic Outcome of Patients With Non-Specific Colitis.
    Am J Gastroenterol. 2021;116.
    >> Share

  43. GUEORGUIEVA I, Jacobs R, Piper M
    P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    >> Share

    October 2021
  44. MAZOR Y, Trieu RQ, Prott G, Jones M, et al
    Volumetric Rectal Perception Testing: Is It Clinically Relevant? Results From a Large Patient Cohort.
    Am J Gastroenterol. 2021 Oct 5. pii: 00000434-990000000-00116.
    >> Share

    September 2021
  45. KAMBOJ AK, Agarwal S, Chedid VG, Iyer PG, et al
    Changes in National Google Trends and Local Healthcare Utilization After High-Impact Gastroenterology Publications.
    Am J Gastroenterol. 2021 Sep 16. pii: 00000434-990000000-00105.
    >> Share

  46. CHANG L, Lacy BE, Moshiree B, Kassebaum A, et al
    Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Am J Gastroenterol. 2021;116:1929-1937.
    >> Share

    July 2021
  47. NEE J, Ballou S, Kelley JM, Kaptchuk TJ, et al
    Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 Jul 28. pii: 00000434-990000000-00060.
    >> Share

  48. KESZTHELYI D
    Irritable Bowel Syndrome and Functional Dyspepsia: Different Ends of the Same Spectrum of Intestinal Barrier Dysfunction?
    Am J Gastroenterol. 2021;116:1556.
    >> Share

    May 2021
  49. SHAH ED, Lacy BE, Chey WD, Chang L, et al
    Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98765.
    >> Share

  50. YU V, Ballou S, Hassan R, Singh P, et al
    Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.
    Am J Gastroenterol. 2021 May 18. pii: 00000434-900000000-98775.
    >> Share

  51. BRENNER DM, Lacy BE
    Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98778.
    >> Share

  52. SCHMULSON M
    Probiotics: To Use or Not to Use? That Is the Question.
    Am J Gastroenterol. 2021 May 10. pii: 00000434-900000000-98783.
    >> Share

    April 2021
  53. GOODOORY VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, et al
    Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021 Apr 6. pii: 00000434-900000000-98826.
    >> Share

  54. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021;116:769-779.
    >> Share

  55. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2021;116:748-757.
    >> Share

    March 2021
  56. BUSHYHEAD DW
    Continuing Medical Education Questions: March 2021: Irritable Bowel Syndrome in.
    Am J Gastroenterol. 2021;116:456.
    >> Share

    February 2021
  57. PLASSE TF
    Reply to Black and Ford.
    Am J Gastroenterol. 2021;116:429.
    >> Share

    January 2021
  58. MOOSAVI S, Pimentel M, Wong MS, Rezaie A, et al
    Irritable Bowel Syndrome in Pregnancy.
    Am J Gastroenterol. 2021 Jan 21. pii: 00000434-900000000-98935.
    >> Share

  59. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    >> Share

  60. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    >> Share

    December 2020
  61. LACY BE, Pimentel M, Brenner DM, Chey WD, et al
    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Dec 14. doi: 10.14309/ajg.0000000000001036.
    >> Share

  62. CHEY WD, Lembo AJ, Yang Y, Rosenbaum DP, et al
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    >> Share

    November 2020
  63. BLACK CJ, Ford AC
    Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000000932.
    >> Share

  64. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Nov 4. doi: 10.14309/ajg.0000000000001038.
    >> Share

  65. STALLER K, Cash BD
    Myths and Misconceptions About Constipation: A New View for the 2020s.
    Am J Gastroenterol. 2020;115:1741-1745.
    >> Share

    October 2020
  66. BLACK CJ, Yiannakou Y, Guthrie EA, West R, et al
    A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000975.
    >> Share

  67. MELCHIOR C, Simren M
    Positive Effect of Bimodal Release Ondansetron in Irritable Bowel Syndrome With Diarrhea: Relevance of Low-Grade Inflammation?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001022.
    >> Share

  68. CHEY WD, Sayuk GS, Bartolini W, Reasner DS, et al
    Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000967.
    >> Share

  69. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000989.
    >> Share

    September 2020
  70. BARBERIO B, Houghton LA, Yiannakou Y, Savarino EV, et al
    Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000946.
    >> Share

  71. MANSUETO P, Soresi M, Candore G, Garlisi C, et al
    Autoimmunity Features in Patients With Non-Celiac Wheat Sensitivity.
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000919.
    >> Share

    August 2020
  72. RUFFLE JK, Tinkler L, Emmett C, Ford AC, et al
    Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000816.
    >> Share

    July 2020
  73. GUILARTE M, Vicario M, Martinez C, de Torres I, et al
    Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Jul 27. doi: 10.14309/ajg.0000000000000789.
    >> Share

    June 2020
  74. PLASSE TF, Barton G, Davidson E, Abramson D, et al
    Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
    Am J Gastroenterol. 2020 Jun 24. doi: 10.14309/ajg.0000000000000727.
    >> Share

  75. CAMILLERI M, Vijayvargiya P
    The Role of Bile Acids in Chronic Diarrhea.
    Am J Gastroenterol. 2020 Jun 11. doi: 10.14309/ajg.0000000000000696.
    >> Share

  76. REZAIE A
    Shedding Light on Elevated Baseline Hydrogen and Flat-Line Patterns During Breath Testing.
    Am J Gastroenterol. 2020;115:956-957.
    >> Share

    May 2020
  77. WILSON B, Rossi M, Kanno T, Parkes GC, et al
    beta-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000641.
    >> Share

    April 2020
  78. OH SJ, Fuller G, Patel D, Khalil C, et al
    Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
    Am J Gastroenterol. 2020 Apr 23. doi: 10.14309/ajg.0000000000000614.
    >> Share

    March 2020
  79. BLACK CJ, Ford AC
    Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives.
    Am J Gastroenterol. 2020 Mar 2. doi: 10.14309/ajg.0000000000000569.
    >> Share

  80. BRENNER DM, Sayuk GS, Gutman CR, Jo E, et al
    Response to Black et al.
    Am J Gastroenterol. 2020;115:484-485.
    >> Share

    February 2020
  81. STALLER K, Olen O, Soderling J, Roelstraete B, et al
    Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study.
    Am J Gastroenterol. 2020 Feb 28. doi: 10.14309/ajg.0000000000000573.
    >> Share

  82. DEUTSCH JK, Levitt J, Hass DJ
    Complementary and Alternative Medicine for Functional Gastrointestinal Disorders.
    Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000539.
    >> Share

  83. SHAH ED, Suresh S, Jou J, Chey WD, et al
    Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000530.
    >> Share

    January 2020
  84. CHEY WD, Lembo AJ, Rosenbaum DP
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).
    Am J Gastroenterol. 2020 Jan 13. doi: 10.14309/ajg.0000000000000516.
    >> Share

  85. BUTT I, Kasmin F, Ekekezie C, Perler BK, et al
    Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000499.
    >> Share

  86. BLACK CJ, Houghton LA, Ford AC
    Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000518.
    >> Share

  87. SHAH A, Talley NJ, Jones M, Kendall BJ, et al
    Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000504.
    >> Share

  88. SHAH ED, Almario CV, Spiegel BM, Chey WD, et al
    Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000502.
    >> Share

  89. TALLEY NJ
    What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model.
    Am J Gastroenterol. 2020;115:41-48.
    >> Share

    November 2019
  90. REZAIE A, Heimanson Z, McCallum R, Pimentel M, et al
    Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2019 Nov 1. doi: 10.14309/ajg.0000000000000444.
    >> Share

    October 2019
  91. SCALLAN WALTER EJ, Crim SM, Bruce BB, Griffin PM, et al
    Postinfectious Irritable Bowel Syndrome After Campylobacter Infection.
    Am J Gastroenterol. 2019;114:1649-1656.
    >> Share

    September 2019
  92. DYDYK AM, Gupta N, Rej A, Trott N, et al
    A Gluten-Free Diet: The Express Route to Fructan Reduction.
    Am J Gastroenterol. 2019;114:1553.
    >> Share

    July 2019
  93. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Response to Lai.
    Am J Gastroenterol. 2019;114:1177-1178.
    >> Share

  94. LAI SW
    Safety of Eluxadoline Use.
    Am J Gastroenterol. 2019;114:1176-1177.
    >> Share

    February 2019
  95. SCARLATA K
    Low FODMAP Diet: What Your Patients Need to Know.
    Am J Gastroenterol. 2019;114:189-191.
    >> Share

    January 2019
  96. SCHOENFELD P, Shah ED
    Response to Sierra and Gomez.
    Am J Gastroenterol. 2019;114:169-170.
    >> Share

  97. SIERRA F, Gomez DG
    Efficacy and Tolerability of Guanylate Cyclase-C Agonist: Encouraging Results With Insignificant Clinical Importance.
    Am J Gastroenterol. 2019;114:169.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016